ENTITY
Natco Pharma

Natco Pharma (NTCPH IN)

31
Analysis
Health CareIndia
Natco Pharma Limited manufactures a comprehensive range of branded and generic dosage forms, bulk actives and intermediates for both Indian as well as International markets. The Company's product range is constantly expanded through its own R&D initiative, basic research and also through joint ventures, technology transfers and collaborations.
more
bullishNatco Pharma
19 Sep 2024 09:04

The "What's Left In India" Screen: 80 Stocks with High ROEs and Relatively Lower PEs

We compile a list of 80 Indian stocks based on two simple criteria: PE and ROE. Given the market's lofty valuations, we title it "The What's Left...

Logo
643 Views
Share
11 Mar 2024 21:23

Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener

We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...

Logo
328 Views
Share
bullishMankind Pharma
08 Feb 2023 09:48

Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins

Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.

Logo
459 Views
Share
10 Nov 2024 07:30

APAC Healthcare Weekly (Nov 10)- Alteogen, Santen Pharmaceutical, Beigene, Sun Pharmaceutical

​Alteogen partners with Daiichi Sankyo for Enhertu, Volpara secures $7.3M contract, Santen launches Rhopressa in South Korea, Sun Pharma's Leqselvi...

Logo
598 Views
Share
03 Nov 2024 22:29

Ipca Laboratories (IPCA IN): Domestic Revenue Drives Q1FY25 Result; Full-Year Margin Guidance Raise

Ipca will announce Q2FY25 result on November 14. Thus far, Indian pharma companies have reported strong domestic revenue. We are expecting similar...

Logo
612 Views
Share
x